The pharmaceutical company said its board will consider 2-for-1 stock split on 13 November 2021.
The board will consider splitting each share of face value Rs 2 each into two shares of face value of Re 1 each.On 13 November 2021, the company's board will also consider Q2 results and interim dividend.
On a consolidated basis, net profit of IPCA Laboratories declined 31.26% to Rs 306.66 crore on 2.05% rise in net sales to Rs 1565.79 crore in Q1 June 2021 over Q1 June 2020.
IPCA is a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. It is one of the world's largest manufacturers and suppliers of over a dozen APIs.
Shares of IPCA Laboratories were down 1.03% at Rs 2,322. The stock hit a high of Rs 2,397.40 and a low of Rs 2,281.45 so far during the day.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app